No Data
Express News | Celularity Receives FDA Tissue Reference Group Recommendation Letters for Its Natalin and Acelagraft™ Wound Care Products
Celularity Receives FDA Tissue Reference Group Recommendation Letters for Its Natalin and Acelagraft Wound Care Products
Express News | Cellularity Shares Are Trading Higher After the Company Announced a Master Services Collaboration With BlueSphere Bio to Manufacture BSB Cell Therapy Products
Elularity Announces Master Services Collaboration With BlueSphere Bio For Manufacturing BSB Cell Therapy Products, Utilizing Florham Park CGMP Facility; Project Involves 37K Sq Ft Space, Focus On TCR T Cell Therapy For AML
Celularity Enters Strategic Collaboration Agreement With Clinical Stage Cell Therapy Company
Revenues Working Against Celularity Inc.'s (NASDAQ:CELU) Share Price Following 27% Dive
